Young people have fallen behind on vaccinations during the pandemic, experts say. Can the COVID-19 vaccine help change that?
The pending availability of a second COVID-19 vaccine for 12- to 17-year-olds has local infectious diseases experts hopeful it will spur young people to catch up on all vaccinations. Moderna said Tuesday that the first dose of its vaccine was 93% effective in that age range following a study on more than 3,700 young people. The drug maker said it saw no COVID-19 diagnoses in study participants who got two doses. The company plans to submit its data in early June to the Food and Drug Administration for the same emergency-use authorization given to the Pfizer vaccine. "Our vaccination sites con...